Suppression of Retinoic Acid Receptor–β in Premalignant Oral Lesions and Its Up-Regulation by Isotretinoin
Open Access
- 25 May 1995
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 332 (21) , 1405-1411
- https://doi.org/10.1056/nejm199505253322103
Abstract
Retinoids are effective in the treatment and prevention of certain human cancers. Most of their actions are thought to result from changes in gene expression mediated by nuclear retinoic acid receptors and retinoid X receptors. We conducted a study to determine whether the expression of these receptors was altered in premalignant oral lesions and, if so, whether their expression could be restored by treatment with isotretinoin. We performed in situ hybridization of retinoic acid receptors and retinoid X receptors using antisense riboprobes in specimens of oral mucosa from 7 normal subjects and specimens of premalignant oral lesions from 52 patients before treatment with isotretinoin and from 39 of the 52 patients after three months of treatment. All the normal specimens expressed retinoic acid receptor–β messenger RNA (mRNA). In contrast, retinoic acid receptor–β mRNA was detected in only 21 of the 52 premalignant oral lesions (P = 0.003). Thirty-five of the 39 specimens available for evaluation after treatment expressed retinoic acid receptor–β mRNA (P<0.001). All normal and premalignant specimens expressed similar levels of mRNA for retinoic acid receptor–α and retinoic acid receptor–γ and the three types of retinoid X receptors, α, β, and γ. The levels of retinoic acid receptor–β mRNA increased in the specimens from 18 of the 22 patients who had responses to isotretinoin and in 8 of the 17 specimens from the patients without responses (P = 0.04). The expression of retinoic acid receptor–β mRNA is selectively lost in premalignant oral lesions and can be restored by treatment with isotretinoin. Restoration of the expression of retinoic acid receptor–β mRNA is associated with a clinical response. Retinoic acid receptor–β may have a role in mediating the response to retinoids and may be a useful intermediate biologic marker in trials of these agents for the prevention of oral carcinogenesis.Keywords
This publication has 32 references indexed in Scilit:
- Estrogen Receptor-Associated Proteins: Possible Mediators of Hormone-Induced TranscriptionScience, 1994
- Detection of Nuclear Retinoic Acid Receptor mRNA in Histological Tissue Sections Using Nonradioactive In Situ Hybridization HistochemistryDiagnostic Molecular Pathology, 1994
- Vertebrate receptors: molecular biology, dimerization and response elementsSeminars in Cell Biology, 1994
- Enhancement of Regression of Cervical Intraepithelial Neoplasia II (Moderate Dysplasia) With Topically Applied All- trans -Retinoic Acid: a Randomized TrialJNCI Journal of the National Cancer Institute, 1994
- E1A functions as a coactivator of retinoic acid-dependent retinoic acid receptor-beta 2 promoter activationMolecular Endocrinology, 1993
- Head and Neck CancerNew England Journal of Medicine, 1993
- Retinoic acid receptor isoform RAR? 1: an antagonist of the transactivation of the RAR? RARE in epithelial cell lines and normal human keratinocytesMolecular Biology Reports, 1993
- Variable expression of retinoie acid receptor (RARβ) mRNA in human oral and epidermal keratinocytes; relation to keratin 19 expression and keratinization potentialDifferentiation, 1991
- Differential effects of all-trans and 13-cis-retinoic acid on mRNA levels of nuclear retinoic acid receptors in rat lung and liverBiochemical and Biophysical Research Communications, 1991
- 13-cis-Retinoic Acid in the Treatment of Oral LeukoplakiaNew England Journal of Medicine, 1986